Comparative Studies on the Therapeutic Benefit of Targeted α-Particle Radiation Therapy for the Treatment of Disseminated Intraperitoneal Disease

Gelijkaardige items

• Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab
  door: Milenic, Diane E., et al.
  Gepubliceerd in: (2017)
• Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease
  door: Milenic, Diane E, et al.
  Gepubliceerd in: (2015)
• Exploration of a F(ab′)(2) Fragment as the Targeting Agent of α-Radiation Therapy: A Comparison of the Therapeutic Benefit of Intraperitoneal and Intravenous Administered Radioimmunotherapy
  door: Milenic, Diane E., et al.
  Gepubliceerd in: (2018)
• Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts
  door: Yong, Kwon Joong, et al.
  Gepubliceerd in: (2016)
• Evaluation of Platinum Chemotherapy in Combination with HER2-Targeted α-Particle Radiation
  door: Milenic, Diane E., et al.
  Gepubliceerd in: (2013)